Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

The board of Pfizer Inc. ( NYSE:PFE ) has announced that it will be paying its dividend of $0.43 on the 7th of ...

The final four dividend stocks to buy and hold in 2025 are a mixed assortment. The common denominators between these stocks ...

PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

Donald Trump’s allies have raised over $200 million to fund his inauguration, political operations, and presidential library.

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American ...

Explore the recent performance of the SCHD ETF's performance in 2024 and what to expect in the next few months and why it may ...

Long-standing partnership as strong foundation for extended collaboration Expanded cooperation in global RISE with SAP ...

These four S&P 500 stocks pay 6% and higher dividends, have Buy ratings at top Wall Street firms, and are offering excellent ...

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...